As part of our ongoing commitment to sustainability, Chiesi has updated its Code of Interdependence, aligning it with the latest industry standards and best practices. By focusing on the Sustainable Development Goals (SDGs) where we and our partners can have the greatest impact, we actively contribute to the 2030 Sustainability Agenda.
 

Sustainability and inclusivity are at the heart of Chiesi’s approach to the pharmaceutical industry. Our Code of Interdependence, which serves as the Group’s Value Chain Code of Conduct, has recently been updated to better reflect our evolving goals and the latest industry standards.
 

The updated Code aligns with the 2023 Pharmaceutical Supply Chain Initiative (PSCI) principles, and incorporates the Science-Based Targets initiative (SBTi) as a foundation to promote best practices in emissions reductions and net-zero targets in line with climate science. Additionally, it reflects updates in internal policies, practices, procedures, and relevant regulations.
 

A key aspect of this revision was collaboration. During the September 2024 workshop, we engaged with our partners, gathering their insights and feedback. Combined with extensive benchmark analyses, these contributions have strengthened the framework, making it an even more effective tool for sustainable progress.
 

More than just a set of guidelines, the Code of Interdependence serves as a resource for Chiesi’s entire value chain—including suppliers, partners, and distributors—to advance toward more sustainable and inclusive business practices.
 

With this update, Chiesi is reinforcing its commitment to broadening the adoption of sustainable principles across its value chain, marking a significant step forward in our collective journey toward a more responsible and inclusive future.

 

 Read the new Code of Interdependence